NOTE: All events are in Eastern Daylight Time Zone. Please visit your Symposium Profile to verify your time zone. We recommend displaying all times in the event time zone.
Investigational New Drug, Device and Therapeutics Symposium
A phase 2a, randomized, open-label study to evaluate multiple dosing regimens of subcutaneous ALXN1820 in adult patients with sickle cell disease
